10-Q Filing

Dominari Holdings Inc. CIK: 12239 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001615774-17-004286`
Period End Date	20170630
Filing Date	20170811
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	spex-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 70 Cash Flow Statement 70

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$134.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$392.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$142.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$733.00K	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$6.03M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$2.92M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$135.00K	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$95.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.75M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.29M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	4.94M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.00K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	4.98M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	4.94M	shares	Point-in-time
Patent portfolios and patent rights, net	`FiniteLivedIntangibleAssetsNet`	$4.95M	USD	Point-in-time
Patent portfolios and patent rights, net	`FiniteLivedIntangibleAssetsNet`	$4.27M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	4.98M	shares	Point-in-time
Treasury stock	`TreasuryStockShares`	12.00	shares	Point-in-time
Investments at fair value	`Investments`	$675.00K	USD	Point-in-time
Investments at fair value	`Investments`	-	USD	Point-in-time
Treasury stock	`TreasuryStockShares`	12.00	shares	Point-in-time
Deposit	`DepositsAssetsNoncurrent`	$26.00K	USD	Point-in-time
Deposit	`DepositsAssetsNoncurrent`	$26.00K	USD	Point-in-time
Total assets	`Assets`	$8.72M	USD	Point-in-time
Total assets	`Assets`	$11.28M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$103.00K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$123.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$446.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$82.00K	USD	Point-in-time
Warrant liabilities	`DerivativeLiabilitiesNoncurrent`	$702.00K	USD	Point-in-time
Warrant liabilities	`DerivativeLiabilitiesNoncurrent`	$2.03M	USD	Point-in-time
Short-term deferred revenue	`DeferredRevenue`	$1.07M	USD	Point-in-time
Short-term deferred revenue	`DeferredRevenue`	$1.22M	USD	Point-in-time
Short-term lease liabilities	`CapitalLeaseObligationsCurrent`	$140.00K	USD	Point-in-time
Short-term lease liabilities	`CapitalLeaseObligationsCurrent`	$183.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.67M	USD	Point-in-time
Long-term deferred revenue	`DeferredRevenueNoncurrent`	$3.25M	USD	Point-in-time
Long-term deferred revenue	`DeferredRevenueNoncurrent`	$2.77M	USD	Point-in-time
Long-term lease liabilities	`DeferredRentCreditNoncurrent`	-	USD	Point-in-time
Long-term lease liabilities	`DeferredRentCreditNoncurrent`	$44.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$6.20M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.96M	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 4,979,910 and 4,943,941 shares issued at June 30, 2017 and December 31, 2016, respectively; 4,979,898 and 4,943,929 shares outstanding at June 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 4,979,910 and 4,943,941 shares issued at June 30, 2017 and December 31, 2016, respectively; 4,979,898 and 4,943,929 shares outstanding at June 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$147.33M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$147.32M	USD	Point-in-time
Treasury stock, at cost, 12 shares at June 30, 2017 and December 31, 2016	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Treasury stock, at cost, 12 shares at June 30, 2017 and December 31, 2016	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-141.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-144.53M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$2.53M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.32M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$11.28M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$8.72M	USD	Point-in-time

Income Statement 70 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$311.00K	USD	1 Quarter
Revenues	`Revenues`	$249.00K	USD	2 Qtrs
Revenues	`Revenues`	$638.00K	USD	2 Qtrs
Revenues	`Revenues`	$177.00K	USD	1 Quarter
Amortization of patent portfolio	`AdjustmentForAmortization`	$343.00K	USD	1 Quarter
Amortization of patent portfolio	`AdjustmentForAmortization`	$531.00K	USD	1 Quarter
Amortization of patent portfolio	`AdjustmentForAmortization`	$681.00K	USD	2 Qtrs
Amortization of patent portfolio	`AdjustmentForAmortization`	$1.06M	USD	2 Qtrs
Compensation and related expenses (including stock-based compensation)	`EmployeeBenefitsAndShareBasedCompensation`	$673.00K	USD	2 Qtrs
Compensation and related expenses (including stock-based compensation)	`EmployeeBenefitsAndShareBasedCompensation`	$883.00K	USD	2 Qtrs
Compensation and related expenses (including stock-based compensation)	`EmployeeBenefitsAndShareBasedCompensation`	$294.00K	USD	1 Quarter
Compensation and related expenses (including stock-based compensation)	`EmployeeBenefitsAndShareBasedCompensation`	$361.00K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$824.00K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$250.00K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$535.00K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$1.53M	USD	2 Qtrs
Rent	`LeaseAndRentalExpense`	$23.00K	USD	1 Quarter
Rent	`LeaseAndRentalExpense`	$45.00K	USD	2 Qtrs
Rent	`LeaseAndRentalExpense`	$49.00K	USD	2 Qtrs
Rent	`LeaseAndRentalExpense`	$27.00K	USD	1 Quarter
Other selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$174.00K	USD	1 Quarter
Other selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$60.00K	USD	1 Quarter
Other selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$123.00K	USD	2 Qtrs
Other selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$236.00K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$3.43M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.80M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.38M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.09M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.75M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-777.00K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.18M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.62M	USD	1 Quarter
Other income, net	`OtherIncome`	$25.00K	USD	2 Qtrs
Other income, net	`OtherIncome`	$121.00K	USD	1 Quarter
Other income, net	`OtherIncome`	$293.00K	USD	2 Qtrs
Other income, net	`OtherIncome`	$55.00K	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$1.20M	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-1.03M	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$1.33M	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$511.00K	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$-1.03M	USD	2 Qtrs
Total other (expenses) income	`NonoperatingIncomeExpense`	$-1.08M	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$-456.00K	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$1.06M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.78M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.86M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.13M	USD	2 Qtrs
Deemed capital contribution on extinguishment of preferred stock	`ConvertiblePreferredStockConvertedToOtherSecurities`	$-31.48M	USD	1 Quarter
Deemed capital contribution on extinguishment of preferred stock	`ConvertiblePreferredStockConvertedToOtherSecurities`	$-31.48M	USD	2 Qtrs
Net income (loss) attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.86M	USD	1 Quarter
Net income (loss) attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$29.35M	USD	2 Qtrs
Net income (loss) attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$29.40M	USD	1 Quarter
Net income (loss) attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.78M	USD	2 Qtrs
Basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$9.61	USD	1 Quarter
Basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$10.18	USD	2 Qtrs
Basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.38	USD	1 Quarter
Basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.56	USD	2 Qtrs
Diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.38	USD	1 Quarter
Diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$9.32	USD	2 Qtrs
Diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$9.21	USD	1 Quarter
Diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.56	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	4.95M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	3.06M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	4.96M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	2.88M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	4.96M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	4.95M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	3.19M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	3.15M	shares	2 Qtrs

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.78M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.86M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.13M	USD	2 Qtrs
Amortization of patent portfolio	`AdjustmentForAmortization`	$343.00K	USD	1 Quarter
Amortization of patent portfolio	`AdjustmentForAmortization`	$531.00K	USD	1 Quarter
Amortization of patent portfolio	`AdjustmentForAmortization`	$681.00K	USD	2 Qtrs
Amortization of patent portfolio	`AdjustmentForAmortization`	$1.06M	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentsForWarrantLiabilities`	$1.03M	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentsForWarrantLiabilities`	$-1.33M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$299.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$167.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$11.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$8.00K	USD	1 Quarter
Depreciation expenses	`Depreciation`	$2.00K	USD	2 Qtrs
Depreciation expenses	`Depreciation`	$1.00K	USD	2 Qtrs
Realized loss on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-129.00K	USD	2 Qtrs
Realized loss on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-36.00K	USD	1 Quarter
Realized loss on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-57.00K	USD	2 Qtrs
Realized loss on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$10.00K	USD	1 Quarter
Unrealized gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$17.00K	USD	1 Quarter
Unrealized gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$29.00K	USD	2 Qtrs
Unrealized gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$66.00K	USD	1 Quarter
Unrealized gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$137.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-231.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-40.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-124.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-20.00K	USD	2 Qtrs
Accrued salaries and benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-364.00K	USD	2 Qtrs
Accrued salaries and benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-571.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInOtherDeferredLiability`	$-618.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInOtherDeferredLiability`	$4.13M	USD	2 Qtrs
Accrued lease liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-90.00K	USD	2 Qtrs
Accrued lease liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-87.00K	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.82M	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$1.80M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$6.51M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$10.19M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$7.89M	USD	2 Qtrs
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$9.62M	USD	2 Qtrs
Investment in Hoth Therapeutics, Inc.	`PaymentsToAcquireInterestInJointVenture`	$675.00K	USD	2 Qtrs
Investment in Hoth Therapeutics, Inc.	`PaymentsToAcquireInterestInJointVenture`	-	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-2.31M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$2.44M	USD	2 Qtrs
Cash paid for cancellation of common stock	`CashPaidForCancellationOfCommonStock`	-	USD	2 Qtrs
Cash paid for cancellation of common stock	`CashPaidForCancellationOfCommonStock`	$4.00K	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$760.00K	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Repurchase of restricted stock units to pay for employee withholding taxes	`PaymentsForRepurchaseOfOtherEquity`	$24.00K	USD	2 Qtrs
Repurchase of restricted stock units to pay for employee withholding taxes	`PaymentsForRepurchaseOfOtherEquity`	-	USD	2 Qtrs
Net cash (used in) provided byfinancing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-24.00K	USD	2 Qtrs
Net cash (used in) provided byfinancing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$756.00K	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$599.00K	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$250.00K	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$134.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$392.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$142.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$733.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$134.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$392.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$142.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$733.00K	USD	Point-in-time
Cash paid for interest and taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid for interest and taxes	`IncomeTaxesPaid`	$114.00K	USD	2 Qtrs
Extinguishment of Series H Convertible Preferred Stock in connection with license agreement	`ExtinguishmentOfSeriesHConvertiblePreferredStockInConnectionWithLicenseAgreement`	$31.48M	USD	2 Qtrs
Extinguishment of Series H Convertible Preferred Stock in connection with license agreement	`ExtinguishmentOfSeriesHConvertiblePreferredStockInConnectionWithLicenseAgreement`	-	USD	2 Qtrs
Recognition of deferred revenue in connection with license agreement	`RecognitionOfDeferredRevenueInConnectionWithLicenseAgreement`	$414.00K	USD	2 Qtrs
Recognition of deferred revenue in connection with license agreement	`RecognitionOfDeferredRevenueInConnectionWithLicenseAgreement`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.